-
1
-
-
0031469711
-
The epidemiology of Parkinson's disease
-
Ben-Shlomo Y (1997) The epidemiology of Parkinson's disease.Baillieres Clin Neurol 6(1):55-68.
-
(1997)
Baillieres Clin Neurol
, vol.6
, Issue.1
, pp. 55-68
-
-
Ben-Shlomo, Y.1
-
2
-
-
79955557808
-
Rotenone, paraquat, and Parkinson's disease
-
Tanner CM, et al. (2011) Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect 119(6):866-872.
-
(2011)
Environ Health Perspect
, vol.119
, Issue.6
, pp. 866-872
-
-
Tanner, C.M.1
-
4
-
-
77954171080
-
Mild traumatic brain injury: A risk factor for neurodegeneration
-
Gavett BE, Stern RA, Cantu RC, Nowinski CJ, McKee AC (2010) Mild traumatic brain injury: A risk factor for neurodegeneration. Alzheimers Res Ther 2(3):18.
-
(2010)
Alzheimers Res Ther
, vol.2
, Issue.3
, pp. 18
-
-
Gavett, B.E.1
Stern, R.A.2
Cantu, R.C.3
Nowinski, C.J.4
McKee, A.C.5
-
5
-
-
68249157080
-
Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury
-
McKee AC, et al. (2009) Chronic traumatic encephalopathy in athletes: Progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 68(7):709-735.
-
(2009)
J Neuropathol Exp Neurol
, vol.68
, Issue.7
, pp. 709-735
-
-
McKee, A.C.1
-
6
-
-
1942454250
-
Inflammation and neurodegeneration in Parkinson's disease
-
McGeer PL, McGeer EG (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10(Suppl 1):S3-S7.
-
(2004)
Parkinsonism Relat Disord
, vol.10
, pp. S3-S7
-
-
McGeer, P.L.1
McGeer, E.G.2
-
7
-
-
33645559991
-
Inflammation and infection in Parkinson's disease
-
Arai H, Furuya T, Mizuno Y, Mochizuki H (2006) Inflammation and infection in Parkinson's disease. Histol Histopathol 21(6):673-678.
-
(2006)
Histol Histopathol
, vol.21
, Issue.6
, pp. 673-678
-
-
Arai, H.1
Furuya, T.2
Mizuno, Y.3
Mochizuki, H.4
-
8
-
-
84864772346
-
Association of Parkinson's disease with infections and occupational exposure to possible vectors
-
Harris MA, Tsui JK, Marion SA, Shen H, Teschke K (2012) Association of Parkinson's disease with infections and occupational exposure to possible vectors. Mov Disord 27(9):1111-1117.
-
(2012)
Mov Disord
, vol.27
, Issue.9
, pp. 1111-1117
-
-
Harris, M.A.1
Tsui, J.K.2
Marion, S.A.3
Shen, H.4
Teschke, K.5
-
10
-
-
77958152812
-
Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries
-
Henry J, Smeyne RJ, Jang H, Miller B, Okun MS (2010) Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries. Parkinsonism Relat Disord 16(9):566-571.
-
(2010)
Parkinsonism Relat Disord
, vol.16
, Issue.9
, pp. 566-571
-
-
Henry, J.1
Smeyne, R.J.2
Jang, H.3
Miller, B.4
Okun, M.S.5
-
11
-
-
69549120391
-
Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration
-
Jang H, et al. (2009) Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA 106(33):14063-14068.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, Issue.33
, pp. 14063-14068
-
-
Jang, H.1
-
12
-
-
0021921441
-
Why was the 1918 influenza pandemic so lethal? The possible role of a neurovirulent neuraminidase
-
Maurizi CP (1985) Why was the 1918 influenza pandemic so lethal? The possible role of a neurovirulent neuraminidase. Med Hypotheses 16(1):1-5.
-
(1985)
Med Hypotheses
, vol.16
, Issue.1
, pp. 1-5
-
-
Maurizi, C.P.1
-
13
-
-
77955366745
-
Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: Implications for Parkinson's disease pathogenesis and therapies
-
Oueslati A, Fournier M, Lashuel HA (2010) Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: Implications for Parkinson's disease pathogenesis and therapies. Prog Brain Res 183:115-145.
-
(2010)
Prog Brain Res
, vol.183
, pp. 115-145
-
-
Oueslati, A.1
Fournier, M.2
Lashuel, H.A.3
-
14
-
-
33947505619
-
Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo
-
Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB (2007) Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J Neurosci27(12):3338-3346.
-
(2007)
J Neurosci
, vol.27
, Issue.12
, pp. 3338-3346
-
-
Periquet, M.1
Fulga, T.2
Myllykangas, L.3
Schlossmacher, M.G.4
Feany, M.B.5
-
15
-
-
34548341065
-
The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease
-
Michell AW, et al. (2007) The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease. Cell Transplant 16(5):461-474.
-
(2007)
Cell Transplant
, vol.16
, Issue.5
, pp. 461-474
-
-
Michell, A.W.1
-
16
-
-
77955141273
-
Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology
-
Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M (2010) Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology. Eur J Neurosci 32(3):409-422.
-
(2010)
Eur J Neurosci
, vol.32
, Issue.3
, pp. 409-422
-
-
Ulusoy, A.1
Febbraro, F.2
Jensen, P.H.3
Kirik, D.4
Romero-Ramos, M.5
-
17
-
-
39749196233
-
Selective loss of nigral dopamine neurons induced by over-expression of truncated human alpha-synuclein in mice
-
Wakamatsu M, et al. (2008) Selective loss of nigral dopamine neurons induced by over-expression of truncated human alpha-synuclein in mice. Neurobiol Aging 29(4):574-585.
-
(2008)
Neurobiol Aging
, vol.29
, Issue.4
, pp. 574-585
-
-
Wakamatsu, M.1
-
18
-
-
84867571567
-
Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease
-
Prasad K, Beach TG, Hedreen J, Richfield EK (2012) Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease. Brain Pathol 22(6):811-825.
-
(2012)
Brain Pathol
, vol.22
, Issue.6
, pp. 811-825
-
-
Prasad, K.1
Beach, T.G.2
Hedreen, J.3
Richfield, E.K.4
-
19
-
-
13844320376
-
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
-
Li W, et al. (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci USA 102(6):2162-2167.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.6
, pp. 2162-2167
-
-
Li, W.1
-
20
-
-
0142154275
-
Alpha-synuclein degradation by serine protease neurosin: Implication for pathogenesis of synucleinopathies
-
Iwata A, et al. (2003) Alpha-synuclein degradation by serine protease neurosin: Implication for pathogenesis of synucleinopathies. Hum Mol Genet 12(20):2625-2635.
-
(2003)
Hum Mol Genet
, vol.12
, Issue.20
, pp. 2625-2635
-
-
Iwata, A.1
-
21
-
-
77950021983
-
Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations
-
Lewis KA, Yaeger A, DeMartino GN, Thomas PJ (2010) Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations. J Bioenerg Biomembr 42(1):85-95.
-
(2010)
J Bioenerg Biomembr
, vol.42
, Issue.1
, pp. 85-95
-
-
Lewis, K.A.1
Yaeger, A.2
DeMartino, G.N.3
Thomas, P.J.4
-
22
-
-
78650221707
-
Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology
-
Lewis KA, et al. (2010) Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology. Am J Pathol 177(6):3037-3050.
-
(2010)
Am J Pathol
, vol.177
, Issue.6
, pp. 3037-3050
-
-
Lewis, K.A.1
-
23
-
-
0043233011
-
Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro
-
Mishizen-Eberz AJ, et al. (2003) Distinct cleavage patterns of normal and pathologic forms of alpha-synuclein by calpain I in vitro. J Neurochem 86(4):836-847.
-
(2003)
J Neurochem
, vol.86
, Issue.4
, pp. 836-847
-
-
Mishizen-Eberz, A.J.1
-
24
-
-
21644446495
-
Proteolytic cleavage of extracellular secreted alpha-synuclein via matrix metalloproteinases
-
Sung JY, et al. (2005) Proteolytic cleavage of extracellular secreted alpha-synuclein via matrix metalloproteinases. J Biol Chem 280(26):25216-25224.
-
(2005)
J Biol Chem
, vol.280
, Issue.26
, pp. 25216-25224
-
-
Sung, J.Y.1
-
25
-
-
51549106105
-
Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species
-
Sevlever D, Jiang P, Yen SH (2008) Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 47(36):9678-9687.
-
(2008)
Biochemistry
, vol.47
, Issue.36
, pp. 9678-9687
-
-
Sevlever, D.1
Jiang, P.2
Yen, S.H.3
-
26
-
-
84928050252
-
Mechanisms of inflammasome activation: Recent advances and novel insights
-
Vanaja SK, Rathinam VAK, Fitzgerald KA (2015) Mechanisms of inflammasome activation: Recent advances and novel insights. Trends Cell Biol 25(5):308-315.
-
(2015)
Trends Cell Biol
, vol.25
, Issue.5
, pp. 308-315
-
-
Vanaja, S.K.1
Rathinam, V.A.K.2
Fitzgerald, K.A.3
-
27
-
-
0345189364
-
Yeast cells provide insight into alpha-synuclein biology and pathobiology
-
Outeiro TF, Lindquist S (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302(5651):1772-1775.
-
(2003)
Science
, vol.302
, Issue.5651
, pp. 1772-1775
-
-
Outeiro, T.F.1
Lindquist, S.2
-
28
-
-
13844320376
-
Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
-
Li W, et al. (2005) Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations. Proc Natl Acad Sci USA 102(6):2162-2167.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, Issue.6
, pp. 2162-2167
-
-
Li, W.1
-
30
-
-
77951683942
-
A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety
-
Boxer MB, et al. (2010) A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. ChemMedChem 5(5):730-738.
-
(2010)
ChemMedChem
, vol.5
, Issue.5
, pp. 730-738
-
-
Boxer, M.B.1
-
31
-
-
80055078029
-
A soluble α-synuclein construct forms a dynamic tetramer
-
Wang W, et al. (2011) A soluble α-synuclein construct forms a dynamic tetramer. Proc Natl Acad Sci USA 108(43):17797-17802.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, Issue.43
, pp. 17797-17802
-
-
Wang, W.1
-
32
-
-
84904961684
-
Potential pharmacological chaperones targeting cancer-Associated MCL-1 and Parkinson disease-associated α-synuclein
-
Oh M, et al. (2014) Potential pharmacological chaperones targeting cancer-Associated MCL-1 and Parkinson disease-associated α-synuclein. Proc Natl Acad Sci USA 111(30):11007-11012.
-
(2014)
Proc Natl Acad Sci USA
, vol.111
, Issue.30
, pp. 11007-11012
-
-
Oh, M.1
-
33
-
-
34548341065
-
The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease
-
Michell AW, et al. (2007) The effect of truncated human alpha-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's disease. Cell Transplant 16(5):461-474.
-
(2007)
Cell Transplant
, vol.16
, Issue.5
, pp. 461-474
-
-
Michell, A.W.1
-
34
-
-
20744442130
-
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: Implications for pathogenesis of Parkinson disease
-
Liu CW, et al. (2005) A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: Implications for pathogenesis of Parkinson disease. J Biol Chem 280(24):22670-22678.
-
(2005)
J Biol Chem
, vol.280
, Issue.24
, pp. 22670-22678
-
-
Liu, C.W.1
-
35
-
-
1942454250
-
Inflammation and neurodegeneration in Parkinson's disease
-
McGeer PL, McGeer EG (2004) Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord 10(Suppl 1):S3-S7.
-
(2004)
Parkinsonism Relat Disord
, vol.10
, pp. S3-S7
-
-
McGeer, P.L.1
McGeer, E.G.2
-
36
-
-
0023782375
-
Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
-
McGeer PL, Itagaki S, McGeer EG (1988) Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 76(6):550-557.
-
(1988)
Acta Neuropathol
, vol.76
, Issue.6
, pp. 550-557
-
-
McGeer, P.L.1
Itagaki, S.2
McGeer, E.G.3
-
37
-
-
36249003354
-
Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]-PK11195 PET
-
Bartels AL, Leenders KL (2007) Neuroinflammation in the pathophysiology of Parkinson's disease: Evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord 22(13):1852-1856.
-
(2007)
Mov Disord
, vol.22
, Issue.13
, pp. 1852-1856
-
-
Bartels, A.L.1
Leenders, K.L.2
-
38
-
-
0029417080
-
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients
-
Blum-Degen D, et al. (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202(1-2):17-20.
-
(1995)
Neurosci Lett
, vol.202
, Issue.1-2
, pp. 17-20
-
-
Blum-Degen, D.1
-
39
-
-
0030582991
-
Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease
-
Mogi M, et al. (1996) Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett 211(1):13-16.
-
(1996)
Neurosci Lett
, vol.211
, Issue.1
, pp. 13-16
-
-
Mogi, M.1
-
40
-
-
0028178281
-
Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
-
Mogi M, et al. (1994) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165 (1-2):208-210.
-
(1994)
Neurosci Lett
, vol.165
, Issue.1-2
, pp. 208-210
-
-
Mogi, M.1
-
41
-
-
0028171374
-
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients
-
Mogi M, et al. (1994) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180(2):147-150.
-
(1994)
Neurosci Lett
, vol.180
, Issue.2
, pp. 147-150
-
-
Mogi, M.1
-
42
-
-
49149125924
-
Immunotherapy for neurological diseases
-
Villoslada P, et al. (2008) Immunotherapy for neurological diseases. Clin Immunol 128(3):294-305.
-
(2008)
Clin Immunol
, vol.128
, Issue.3
, pp. 294-305
-
-
Villoslada, P.1
-
43
-
-
33747505812
-
Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy
-
Schwartz M, Butovsky O, Kipnis J (2006) Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy. J Neuroimmune Pharmacol 1(1):4-10.
-
(2006)
J Neuroimmune Pharmacol
, vol.1
, Issue.1
, pp. 4-10
-
-
Schwartz, M.1
Butovsky, O.2
Kipnis, J.3
-
44
-
-
33644854500
-
Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process
-
Dinarello CA (2006) Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am J Clin Nutr 83(2):447S-455S.
-
(2006)
Am J Clin Nutr
, vol.83
, Issue.2
, pp. 447S-455S
-
-
Dinarello, C.A.1
-
45
-
-
79955557808
-
Rotenone, paraquat, and Parkinson's disease
-
Tanner CM, et al. (2011) Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect 119(6):866-872.
-
(2011)
Environ Health Perspect
, vol.119
, Issue.6
, pp. 866-872
-
-
Tanner, C.M.1
-
46
-
-
0036799487
-
Multiple caspases are activated after traumatic brain injury: Evidence for involvement in functional outcome
-
Knoblach SM, et al. (2002) Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma 19(10):1155-1170.
-
(2002)
J Neurotrauma
, vol.19
, Issue.10
, pp. 1155-1170
-
-
Knoblach, S.M.1
-
47
-
-
1442275733
-
Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
-
Furuya T, et al. (2004) Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci 24(8):1865-1872.
-
(2004)
J Neurosci
, vol.24
, Issue.8
, pp. 1865-1872
-
-
Furuya, T.1
-
48
-
-
79956199921
-
Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing
-
Cullen V, et al. (2011) Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing. Ann Neurol 69(6):940-953.
-
(2011)
Ann Neurol
, vol.69
, Issue.6
, pp. 940-953
-
-
Cullen, V.1
-
49
-
-
0037677549
-
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: Role of neuroinflammation
-
Liu B, Gao HM, Hong JS (2003) Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: Role of neuroinflammation. Environ Health Perspect 111(8):1065-1073.
-
(2003)
Environ Health Perspect
, vol.111
, Issue.8
, pp. 1065-1073
-
-
Liu, B.1
Gao, H.M.2
Hong, J.S.3
-
50
-
-
0033601995
-
Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity
-
Klevenyi P, et al. (1999) Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity. Neuroreport 10(3):635-638.
-
(1999)
Neuroreport
, vol.10
, Issue.3
, pp. 635-638
-
-
Klevenyi, P.1
-
51
-
-
0036460861
-
In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain
-
Ling Z, et al. (2002) In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 17(1):116-124.
-
(2002)
Mov Disord
, vol.17
, Issue.1
, pp. 116-124
-
-
Ling, Z.1
-
52
-
-
79955921784
-
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease
-
Gao H-M, et al. (2011) Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Environ Health Perspect 119(6):807-814.
-
(2011)
Environ Health Perspect
, vol.119
, Issue.6
, pp. 807-814
-
-
Gao, H.-M.1
-
53
-
-
0037677549
-
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: Role of neuroinflammation
-
Liu B, Gao HM, Hong JS (2003) Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: Role of neuroinflammation. Environ Health Perspect 111(8):1065-1073.
-
(2003)
Environ Health Perspect
, vol.111
, Issue.8
, pp. 1065-1073
-
-
Liu, B.1
Gao, H.M.2
Hong, J.S.3
-
54
-
-
0033601995
-
Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity
-
Klevenyi P, et al. (1999) Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity. Neuroreport 10(3):635-638.
-
(1999)
Neuroreport
, vol.10
, Issue.3
, pp. 635-638
-
-
Klevenyi, P.1
-
55
-
-
0036460861
-
In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain
-
Ling Z, et al. (2002) In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain. Mov Disord 17(1):116-124.
-
(2002)
Mov Disord
, vol.17
, Issue.1
, pp. 116-124
-
-
Ling, Z.1
-
56
-
-
0035807904
-
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
-
Du Y, et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98(25):14669-14674.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, Issue.25
, pp. 14669-14674
-
-
Du, Y.1
-
57
-
-
84983651724
-
Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy
-
Bassil F, et al. (2016) Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy. Proc Natl Acad Sci USA 113:9593-9598.
-
(2016)
Proc Natl Acad Sci USA
, vol.113
, pp. 9593-9598
-
-
Bassil, F.1
|